While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...
Russo added that they can circulate at other times of year but tend to peak in winter. "Do we have a lot of ...
Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback